{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:20:33Z","timestamp":1762431633845},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ciresp.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T22:13:52Z","timestamp":1552083232000},"page":"222-229","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["El declive de la linfadenectom\u00eda axilar en el c\u00e1ncer de mama. Evoluci\u00f3n de su indicaci\u00f3n durante los \u00faltimos 20 a\u00f1os"],"prefix":"10.1016","volume":"97","author":[{"given":"Alejandra","family":"Garc\u00eda-Novoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benigno","family":"Acea-Nebril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Casal-Beloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bouz\u00f3n-Alejandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cereijo Garea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"G\u00f3mez-Dovigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Builes-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paz","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Mosquera-Oses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ciresp.2019.01.010_bib0250","unstructured":"Galceran J, Ameijide A, Carulla M, Mateos A, Quir\u00f3s JR, Alem\u00e1n A, et al. Estimaciones de la incidencia y la supervivencia del c\u00e1ncer en Espa\u00f1a y su situaci\u00f3n en Europa. Red Espa\u00f1ola de Registros de C\u00e1ncer (REDECAN), 2014."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0255","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM). La cifras del c\u00e1ncer en Espa\u00f1a. 2018 [consultado por \u00faltima vez 16 Dic 2018). Disponible en: https:\/\/seom.org\/seomcms\/images\/stories\/recursos\/Las_Cifras_del_cancer_en_Espana2018.pdf"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3322\/caac.21412","article-title":"Breast cancer statistics 2017, racial disparity in mortality by state","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0265","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0270","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer: A multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0275","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9610(98)00264-5","article-title":"Sentinel lymph node biopsy for staging breast cancer","volume":"176","author":"Rubio","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-739X(02)72000-9","article-title":"Biopsia del ganglio centinela en enfermas con c\u00e1ncer de mama. Resultados de la fase de validaci\u00f3n y efecto de la t\u00e9cnica de marcaje combinado en la identificaci\u00f3n ganglionar y la concordancia histol\u00f3gica","volume":"72","author":"Acea","year":"2002","journal-title":"Cir Esp"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0285","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0300","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomized controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0305","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0310","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: Final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0315","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Version 3.2018. National Comprehensive Cancer Network [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13193-011-0063-9","article-title":"The role of lymph node metastasis in the systemic dissemination of breast cancer","volume":"1","author":"Nathanson","year":"2010","journal-title":"Indian J Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0330","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-10-3277","article-title":"Significance and mechanism of lymph node metastasis in cancer progression","volume":"71","author":"Kawada","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/bcr932","article-title":"The changing global patterns of female breast cancer incidence and mortality","volume":"6","author":"Bray","year":"2004","journal-title":"Breast Can Res."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0340","series-title":"The big squeeze: A social and political history of the controversial mammogram","author":"Reynolds","year":"2012"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0345","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"46","author":"Perou","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0350","first-page":"169","article-title":"Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings","volume":"12","author":"Sacre","year":"1986","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0355","first-page":"705","article-title":"Patient population analysis in EORTC Trial 22881\/10882 on the role of a booster dose in breast conserving therapy","volume":"129","author":"Ptaszynski","year":"1969","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0360","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U","article-title":"Findings from NSABP Protocol NoB-04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers","volume":"48","author":"Fisher","year":"1981","journal-title":"Cancer."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","article-title":"Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up","volume":"22","author":"Louis-Sylvestre","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000167759.15670.14","article-title":"A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up","volume":"242","author":"Martelli","year":"2005","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0375","doi-asserted-by":"crossref","unstructured":"International Breast Cancer Study Group, Rudenstam CM, Zahrjeh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Trial 10-93. J Clin Oncol. 2006; 24: 337-44.","DOI":"10.1200\/JCO.2005.01.5784"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0959-8049(01)81150-3","article-title":"Upstaging of breast cancer patients with PT1 tumours by detection of micrometastasis in sentinel lymph node biopsy (SLND)","volume":"37","author":"Langer","year":"2001","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.sla.0000150255.30665.52","article-title":"Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy","volume":"241","author":"Viale","year":"2005","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0390","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2014.55.5730","article-title":"Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: Planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831","volume":"32","author":"Perez","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0395","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0400","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000658-199904000-00013","article-title":"Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?","volume":"229","author":"Chu","year":"1999","journal-title":"Ann Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0405","unstructured":"Sol\u00e1 M, Micromet\u00e1stasis en el ganglio centinela axilar por c\u00e1ncer de mama. \u00bfEs necesaria la linfadenectom\u00eda axilar completa? Tesis Doctoral. 2013."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0410","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.4725","article-title":"Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer","volume":"91","author":"Cserni","year":"2004","journal-title":"Br J Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0415","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jso.23188","article-title":"The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node","volume":"106","author":"Mazouni","year":"2012","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0420","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.28499","article-title":"Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer. A randomized clinical trial (INT09\/98)","volume":"120","author":"Agresti","year":"2014","journal-title":"Cancer."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0425","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1245\/s10434-013-3193-1","article-title":"Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: A SEER-medicare analysis","volume":"20","author":"Caretta-Weyer","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0430","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0435","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11845-015-1246-0","article-title":"Management of the axilla: Has Z0011 had an impact?","volume":"185","author":"Joyce","year":"2016","journal-title":"Ir J Med Sci."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0440","first-page":"105","article-title":"Repercusi\u00f3n de los criterios ACOSOG Z0011 sobre la indicaci\u00f3n de la linfadenectom\u00eda axilar y el control locorregional en mujeres con ganglio centinela metast\u00e1sico. Resultados preliminares tras cuatro a\u00f1os de aplicaci\u00f3n cl\u00ednica","volume":"28","author":"Acea","year":"2015","journal-title":"Rev Senol Patol Mamar."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0445","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0450","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jamcollsurg.2016.04.048","article-title":"Successful completion of the pilot phase of a randomized controlled trial comparing sentinel lymph node biopsy to no further axillary staging in patients with clinical T1-T2 N0 breast cancer and normal axillary ultrasound","volume":"223","author":"Cyr","year":"2016","journal-title":"J Am Col Surg."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0455","unstructured":"https:\/\/www.boogstudycenter.nl\/studie\/273\/2013-08-lumpectomie.html [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0460","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02466737?term=breast+cancer+lymph+node&rank=56 [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0465","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02049632?term=breast+cancer+lymph+node&rank=162 [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0470","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","article-title":"The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: A Dutch randomized controlled multicentre trial (BOOG 2013-07)","volume":"15","author":"Van Roozendaal","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ciresp.2019.01.010_bib0475","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01717131?term=breast+cancer+lymph+node&rank=11 [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0480","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02240472?term=breast+cancer+lymph+node&rank=73 [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0485","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02335957?term=breast+cancer+lymph+node&rank=125 [consultado por \u00faltima vez: Dic 2018]."},{"key":"10.1016\/j.ciresp.2019.01.010_bib0490","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: A randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin Oncol"}],"container-title":["Cirug\u00eda Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009739X19300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009739X19300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:41:35Z","timestamp":1663083695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009739X19300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0009739X19300284"],"URL":"https:\/\/doi.org\/10.1016\/j.ciresp.2019.01.010","relation":{},"ISSN":["0009-739X"],"issn-type":[{"value":"0009-739X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"El declive de la linfadenectom\u00eda axilar en el c\u00e1ncer de mama. Evoluci\u00f3n de su indicaci\u00f3n durante los \u00faltimos 20 a\u00f1os","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ciresp.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEC. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}